Mirum Pharmaceuticals, Inc.

US$93.72As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MIRMHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR 30.51%
Div yield —
ROE (760.01%)
Biotechnology
Beta (5Y) 0.74
PE TTM —
TSR TTM 29.00%
Mkt cap US$6.118B
ROIC (13.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$91
(3.07%)
(35.45%)
Hold 10|4|2|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.09
1.19
1.20
1.31
18.55%
28.73%
26.97%
29.59%
Revenue$M
554.7
543.1
545.2
566.4
10.86%
8.83%
5.30%
6.91%
Peers (US$6.118B)
Cap (US$)
PE
6.210B
—
6.306B
—
Capital
TTM
5Y
10Y
Leveragex
0.190
0.225
0.235
EBIT/Intx
0.530
0.126
0.126
Own earn%
(18.68)
(91.75)
(98.57)
Sh yield%
11.36
41.09
39.20
Owners
Insiders/Inst%
10.29
39.23
Short interest%
1.46
SBC / revenue%
5.05
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
19–27
$1 testx
—
Incr. ROIC%
0